Literature DB >> 8241370

Group sequential tests for bivariate response: interim analyses of clinical trials with both efficacy and safety endpoints.

C Jennison1, B W Turnbull.   

Abstract

We describe group sequential tests for a bivariate response. The tests are defined in terms of the two response components jointly, rather than through a single summary statistic. Such methods are appropriate when the two responses concern different aspects of a treatment; for example, one might wish to show that a new treatment is both as effective and as safe as the current standard. We present a formulation of the bivariate testing problem, introduce group sequential tests that satisfy Type I error conditions, and show how to find the sample size guaranteeing a specified power. We describe how properties of group sequential tests for bivariate normal observations can be computed by numerical integration.

Entities:  

Mesh:

Year:  1993        PMID: 8241370

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  20 in total

1.  Exact sequential analysis for multiple weighted binomial end points.

Authors:  Ivair R Silva; Joshua J Gagne; Mehdi Najafzadeh; Martin Kulldorff
Journal:  Stat Med       Date:  2019-11-25       Impact factor: 2.373

2.  Testing a primary and a secondary endpoint in a group sequential design.

Authors:  Ajit C Tamhane; Cyrus R Mehta; Lingyun Liu
Journal:  Biometrics       Date:  2010-12       Impact factor: 2.571

3.  A computationally simple bivariate survival estimator for efficacy and safety.

Authors:  Denise Scholtens; Rebecca A Betensky
Journal:  Lifetime Data Anal       Date:  2006-08-18       Impact factor: 1.588

4.  Some Geometric Methods for Constructing Decision Criteria Based On Two-Dimensional Parameters.

Authors:  Peter F Thall
Journal:  J Stat Plan Inference       Date:  2008       Impact factor: 1.111

Review 5.  Design, data monitoring, and analysis of clinical trials with co-primary endpoints: A review.

Authors:  Toshimitsu Hamasaki; Scott R Evans; Koko Asakura
Journal:  J Biopharm Stat       Date:  2017-10-30       Impact factor: 1.051

6.  Sample size determination in group-sequential clinical trials with two co-primary endpoints.

Authors:  Koko Asakura; Toshimitsu Hamasaki; Tomoyuki Sugimoto; Kenichi Hayashi; Scott R Evans; Takashi Sozu
Journal:  Stat Med       Date:  2014-03-27       Impact factor: 2.373

7.  A Rejection Principle for Sequential Tests of Multiple Hypotheses Controlling Familywise Error Rates.

Authors:  Jay Bartroff; Jinlin Song
Journal:  Scand Stat Theory Appl       Date:  2015-05-25       Impact factor: 1.396

8.  Interim evaluation of efficacy or futility in group-sequential trials with multiple co-primary endpoints.

Authors:  Koko Asakura; Toshimitsu Hamasaki; Scott R Evans
Journal:  Biom J       Date:  2016-10-19       Impact factor: 2.207

9.  Sequential Tests of Multiple Hypotheses Controlling Type I and II Familywise Error Rates.

Authors:  Jay Bartroff; Jinlin Song
Journal:  J Stat Plan Inference       Date:  2014-10-01       Impact factor: 1.111

10.  Adjustment on the Type I Error Rate for a Clinical Trial Monitoring for both Intermediate and Primary Endpoints.

Authors:  Susan Halabi
Journal:  J Biom Biostat       Date:  2012-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.